Thoracic costotransverse joint pain patterns: a study in normal volunteers
© Young et al; licensee BioMed Central Ltd. 2008
Received: 25 February 2008
Accepted: 15 October 2008
Published: 15 October 2008
Pain referral patterns of asymptomatic costotransverse joints have not been established. The objective of this study was to determine the pain referral patterns of asymptomatic costotransverse joints via provocative intra-articular injection.
Eight asymptomatic male volunteers received a combined total of 21 intra-articular costotransverse joint injections. Fluoroscopic imaging was used to identify and isolate each costotransverse joint and guide placement of a 25 gauge, 2.5 inch spinal needle into the costotransverse joint. Following contrast medium injection, the quality, intensity, and distribution of the resultant pain produced were recorded.
Of the 21 costotransverse joint injections, 16 (76%) were classified as being intra-articular via arthrograms taken at the time of injection, and 14 of these injections produced a pain sensation distinctly different from that of needle placement. Average pain produced was 3.3/10 on a 0–10 verbal pain scale. Pain was described generally as a deep, dull ache, and pressure sensation. Pain patterns were located superficial to the injected joint, with only the right T2 injections showing referred pain 2 segments cranially and caudally. No chest wall, upper extremity or pseudovisceral pains were reported.
This study provides preliminary data of the pain referral patterns of costotransverse joints. Further research is needed to compare these findings with those elicited from symptomatic subjects.
The thoracic spine has been described as the enigma within the vertebral column, with the diagnosis of pain originating from this region being historically problematic for the practitioner [1–5]. The neural complexity of the thoracic spine, along with referred visceral pain leads to poor pain source localization [6–8]. Research of thoracic spine pain referral patterns has been relatively sparse when compared to the cervical and lumbar spine regions[2, 9–13], despite reports of equally disabling pain from this region[2, 13–16].
The costotransverse and costovertebral joints are often suspected as sources of referred thoracic pain only after costly and often unnecessary negative visceral work-ups have been performed[2, 17–20]. One example is T4 syndrome, a symptom complex originating in the upper thoracic spine and includes glove-like paresthesias of one or both upper limbs, referred pain into the neck and scapular regions, and a dull, aching generalized headache [21–23]. Successful treatment has been reported in case studies using manipulation and exercise intervention [21–23], despite the unknown cause of T4 syndrome. Both the thoracic intervertebral disks and thoracic zygapophyseal joints are thought to be primary pain generators in T4 syndrome based on their pain patterns, suggesting that dysfunction of the costotransverse joint may be implicated as well.
Costotransverse joints cannot be assumed to be a source of pain solely on the basis of pain mapping findings from other joints in the vertebral column. Therefore, pain referral mapping in asymptomatic volunteers can provide information on the potential of the costotransverse joints to be a source of pain, and potentially to recreate clinically observed pain syndromes. This has been undertaken in thoracic zygapophyseal joints, where pain patterns have been documented in asymptomatic volunteers, as well as in subjects with thoracic pain. Clinical pain patterns from the costotransverse joints have been hypothesized[3, 20, 24]. However, pain referral patterns for the costotransverse joints have yet to be definitively investigated. The suspected pain patterns from the costotransverse joints are likely similar to the thoracic zygapophyseal and costovertebral joints. Innervation of the costotransverse joints is from the lateral branch of the thoracic dorsal rami, whereas the thoracic zygapophyseal joints are innervated by the medial branches of the thoracic dorsal rami. Costovertebral joints have been shown to receive sympathetic innervations from the neighboring sympathetic segment and the segment cranial to it. Therefore, the purpose of this study was to identify and record the pain referral pattern of the asymptomatic costotransverse joint, and to stimulate further investigation of the costotransverse joints.
Eight asymptomatic male subjects (36 years ± 7.3 years) without history of thoracic pain participated in the study. This study was approved by the Investigational Review Board at Wilford Hall Medical Center, Lackland Air Force Base, Texas. Informed consent was obtained from all subjects prior to participation. Pretest imaging studies of the costotransverse joints were not performed.
Costotransverse Joint Selection
Subjects were allocated to receive consecutive, same-day right-sided T2, T4 and T6 costotransverse joint injections, or consecutive, same-day left-sided T3, T5 and T7 costotransverse joint injections. Subjects were not blinded to the level of injection, but were blinded to pain pattern responses in prior subjects.
No duration of imaging was stated in the original description of technique reference. Therefore, to minimize exposure to radiation, the total exposure to fluoroscopy was limited to 6 minutes or less per subject, as determined by the Wilford Hall Medical Center Radiation Safety Officer. This was calculated to provide the equivalent amount of radiation as 3.3 years of exposure to natural background radiation (7800 mR).
The technique for injection has been previously described. No sedation was utilized as was reported in the initial technique description. Injections were performed with the patient in the prone position and not the prone oblique position as previously documented due to the inherent mobility of the C-arm fluoroscopy used in this study.
Once the subject was positioned prone, the skin overlying the target joint was prepped with betadine. Using intermittent video fluoroscopy, the target joint space was isolated and the point of needle insertion marked. Xylocaine® (AstraZeneca LP, Wilmington, DE) (1.0%, 2 cc's) was then injected directly under the skin for topical anesthesia. A 25 gauge, 2.5 inch spinal needle was inserted into the underlying costotransverse joint guided by intermittent fluoroscopy toward the identified joint space. Imaging was performed in multiple angles (anteroposterior, as well as 30–45° oblique with a slight cephalic tilt) to guide needle advancement, and for verification of needle placement within the identified joint space as previously described by Dreyfuss. The joint was then injected with ≤ 0.5 cc Omnipaque™ 240 (iohexol) Injection (contrast medium) (GE Healthcare Biosciences/Amersham Health, Piscataway, NJ) under constant imaging to distend the joint. Injection was continued until pain or pressurization of the capsule occurred allowing no additional contrast to be safely injected, or extracapsular spread of the contrast medium was noted by fluoroscopy. An arthrogram was taken to document needle placement, joint selection, and for later data analysis.
All costotransverse joint arthrograms were analyzed to determine the extent of contrast within the joint, and thus to delineate between successful and unsuccessful joint injections. All images were analyzed by one investigator (HG). The following rating scale was utilized:
An arthrogram which clearly outlines the extent of the joint and capsule.
An arthrogram which demonstrates some contrast within the joint, but does not clearly outline the extent of the joint or extravasates outside the joint.
Unable to determine if contrast is within the joint.
Successful joint injections were those rated as either good or equivocal.
Pain and Symptom Assessment
During each injection subjects were asked to distinguish between the sensations of the needle insertion/advancement and capsule distention. The numeric pain rating scale (0 = no pain; 10 = worst imaginable pain) was utilized to report the level of pain induced with capsular distension [27–29]. Subjects were also instructed to describe the pain/sensation induced and any referred pain, utilizing a list of pain descriptors, as well as self-selected descriptors.
Composite Pain Map Construction
The needle insertion point was circled and labeled with a skin marker, and the distribution of pain produced from the joint injection was also marked and labeled on the subject's skin by the injectionist via palpation and verbal interaction with the subject. Once the pain markings were complete, a digital photograph was taken of the pain distributions to allow accurate representation on a composite pain drawing. A separate investigator mapped the pain patterns on a body diagram. A composite pain map was then created from the individual joint maps.
Frequency of costotransverse joint injections and ratings.
# injections attempted
# injections not performed
# Good injections
# Equivocal injections
# Poor injections
Of the 16 successful costotransverse joint injections, 14 (88%) of these injections produced a sensation during capsular distension distinctly different from that of needle placement. One left T3 injection, and one right T4 injection did not produce a pain sensation distinctly different from needle placement. The average pain from capsular distension for the 14 symptom producing injections was 3.3 ( ± 1.8) on the 0–10 numeric pain rating scale.
This is the first study to attempt to document the pain referral patterns of asymptomatic costotransverse joints. We have initiated this process as outlined by Dwyer and colleagues: first, a joint should produce pain when stimulated in normal volunteers; second, in patients with similar forms of pain, the pain should be relieved with anesthetization.
Due to the invasive nature and risk of this type of investigation, we limited this study to a small number of asymptomatic subjects to determine preliminary pain patterns[11, 13]. From the small number of joints stimulated, it appears that there is a reproducible pattern and sensation of pain from asymptomatic costotransverse joints. This pattern was local to the target joint, and consistent with Hilton's Law, which states that the innervation of a joint is the same innervation as the muscles which move the joint and the skin overlying the joint.
The provoked pain patterns significantly overlap the pain patterns described in prior studies stimulating other spinal and soft tissue structures[9, 13, 14]. Therefore, pain patterns are unreliable in diagnosis. Further investigative work to identify symptomatic costotransverse joints will need to be performed to both stimulate and then anesthetize these joints in patients presenting with thoracic pain[10, 30]. This procedure will not only aid in validation of our findings in symptomatic patients, but will also lay the foundation for therapeutic costotransverse joint injections. With a 34–48% prevalence of thoracic zygapophyseal joint pain, and a 42–58% false-positive rate [31–33], it is anticipated that a large number of patients would be required to ascertain true costotransverse joint data.
Two of the successful costotransverse injections (12%) did not provoke a sensation upon capsular distension that was distinguishable from needle insertion/placement. Dreyfuss reported non-painful response to capsular distension in 27% of thoracic zygapophyseal joint injections in asymptomatic subjects. This non-painful response may have been due to an insufficient amount of contrast medium being injected to cause capsular distention[11, 13], or due to the use of a non-irritating injection agent. Although Lau reported injecting a total of 1.7 cc of fluid into the costotransverse joint when describing the costotransverse joint injection technique, no studies have reported on the available volume for this joint. Since the costotransverse joints are anatomically smaller than the zygapophyseal joints, we utilized the amount of fluid injected into the zygapophyseal joints as a baseline for estimating the volume limit for the costotransverse joints. Dreyfess injected between 0.4 to 0.6 ml. Therefore, we elected to limit the volume injected into the costotransverse joint to no greater than 0.5 cc as a precaution to prevent rupturing the joint capsule from overpressurization. Perhaps this amount of contrast was insufficient to cause adequate capsular distension in two of our costotransverse joints to provoke a symptomatic response. However, only 12% of our joints were asymptomatic as compared to 27% of zygapophyseal joints, perhaps suggesting our volume selection was appropriate due to the smaller size of the costotransverse joint compared to the zygapophyseal joint.
We used a non-irritating contrast agent in an attempt to provoke symptoms from capsular distension, similar to the state of joint effusion rather than chemical irritation. However, inflammatory cyctokines released from joint tissue irritated from needle insertion, stimulation of joint capsule nerve endings during needle penetration, and irritation of the joint synovium may have been other sources of elicited symptoms. Our interest was the symptom produced upon the injection of contrast medium into the joint, and patients were asked to distinguish this sensation from that of needle placement. Approximately 1–2 minutes lapsed between the needle placement and the injection of contrast medium, as the needle placement was verified by fluoroscopy from two imaging angles. Non-contrast agents have been used extensively in prior pain pattern studies[11, 13, 35], and have been successfully used to stimulate symptomatic thoracic zygapophyseal joints in an effort to reproduce thoracic pain. Had hypertonic saline been utilized, a potentially more noxious stimulus, the pain referral patterns observed may have been broader in range, more intense, or other clinically reported symptoms may have been provoked[11, 35].
Five of our arthrograms were rated as poor, and thus not included in our analysis. Although we attempted to verify needle placement in each joint before the injection of contrast medium, the intricate anatomy of the costotransverse joint may have been the biggest limitation of our study, possibly limiting the ability to fully place the needle within the joint space. The costotransverse joint is the synovial articulation between the rib tubercle of typical ribs and the vertebral transverse process. The narrow costotransverse joint space is surrounded by a thin articular capsule and strong costotransverse ligaments which tightly bind the joint and limit mobility to slight gliding motions. It is bounded laterally by the rib tubercle and posteriorly by the transverse process, which greatly limits its accessibility. This study is additionally limited by the intricate biomechanical relationship between the costotransverse and costovertebral joints, adding further complexity to the diagnosis of thoracic pain. Finally, it is well documented that pain referral patterns of the spine are insufficient in determining the exact source of pain, because of their overlap. More specific diagnosis and treatment approaches are needed, such as the use of medial branch blocks in the evaluation of potential thoracic zygapophyseal joint mediated pain.
Further studies exploring the pain patterns of the costotransverse joint are needed to validate these findings in symptomatic patients. One possibility would be to stimulate and then anesthetize the costotransverse joints in patients presenting with this pain pattern to determine response, as has been performed in thoracic zygapophyseal joints. Validation of provoked pain patterns has been performed in the cervical spine, demonstrating that the evoked patterns in normal volunteers can be clinically accurate. In developing further studies, alternative imaging techniques for these injections should be considered in an attempt to minimize exposure to radiation. Ultrasound-guided facet injections have initially been studied for cervical and lumbar facets.
This study provides preliminary data on the pain referral patterns of the costotransverse joints. From the small number of joints stimulated, it appears that there is a reproducible pattern and sensation of pain from asymptomatic costotransverse joints.
This study was performed within the current laws of our country and was approved by the Wilford Hall Medical Center Investigational Review Board 3 Mar 2004. No grants or external funding were received for this project.
The opinions and assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of the Department of the Air Force or the Department of Defense.
- Waddell G: The Back Pain Revolution. 1998, New York: Churchill LivingstoneGoogle Scholar
- Benhamou CL, Roux C, Tourliere D, Gervais T, Viala JF, Amor B: Pseudovisceral pain referred from costovertebral arthropathies. Twenty-eight cases. Spine. 1993, 18: 790-795. 10.1097/00007632-199305000-00024.View ArticlePubMedGoogle Scholar
- Fruth SJ: Differential diagnosis and treatment in a patient with posterior upper thoracic pain. Phys Ther. 2006, 86 (2): 254-268.PubMedGoogle Scholar
- Yelland MJ: Back, chest and abdominal pain. How good are spinal signs at identifying musculoskeletal causes of back, chest or abdominal pain?. Aust Fam Physician. 2001, 30: 908-912.PubMedGoogle Scholar
- Singer KP, Edmondston SJ: Introduction: The enigma of the thoracic spine. The Clinical Anatomy and Management of Thoracic Spine Pain. Edited by: Giles LGF, Singer KP. 2000, Oxford: Butterworth-Heinemann, 3-13.Google Scholar
- Stolker RJ, Groen GJ: Medical and invasive management of thoracic spinal pain. The Clinical Anatomy and Management of Thoracic Spine Pain. Edited by: Giles LGF, Singer KP. 2000, Oxford: Butterworth-Heinemann, 206-Google Scholar
- Groen GJ, Stolker RJ: Thoracic neural anatomy. The Clinical Anatomy and Management of Thoracic Spine Pain. Edited by: Giles LGF, Singer KP. 2000, Oxford: Butterworth-Heinemann, 114-Google Scholar
- Bogduk N: Innervations and pain patterns of the thoracic spine. Physical Therapy of the Cervical and Thoracic Spine. Edited by: Grant R. 2002, New York: Churchill Livingstone, 77-3Google Scholar
- Feinstein B, Langton JN, Jameson RM, Schiller F: Experiments on pain referred from deep somatic tissues. J Bone Joint Surg Am. 1954, 36-A: 981-997.PubMedGoogle Scholar
- Aprill C, Dwyer A, Bogduk N: Cervical zygapophyseal joint pain patterns. II: A clinical evaluation. Spine. 1990, 15: 458-461. 10.1097/00007632-199006000-00005.View ArticlePubMedGoogle Scholar
- Dwyer A, Aprill C, Bogduk N: Cervical zygapophyseal joint pain patterns. I: A study in normal volunteers. Spine. 1990, 15: 453-457.View ArticlePubMedGoogle Scholar
- Schwarzer AC, Derby R, Aprill CN, Fortin J, Kine G, Bogduk N: The value of the provocation response in lumbar zygapophyseal joint injections. Clin J Pain. 1994, 10: 309-313.View ArticlePubMedGoogle Scholar
- Dreyfuss P, Tibiletti C, Dreyer SJ: Thoracic zygapophyseal joint pain patterns. A study in normal volunteers. Spine. 1994, 19: 807-811.View ArticlePubMedGoogle Scholar
- Fukui S, Ohseto K, Shiotani M: Patterns of pain induced by distending the thoracic zygapophyseal joints. Reg Anesth. 1997, 22: 332-336. 10.1016/S1098-7339(97)80007-7.View ArticlePubMedGoogle Scholar
- Niemelainen R, Videman T, Battie MC: Prevalence and characteristics of upper or mid-back pain in Finnish men. Spine. 2006, 31: 1846-1849. 10.1097/01.brs.0000226022.05420.1f.View ArticlePubMedGoogle Scholar
- Occhipinti E, Colombini D, Grieco A: Study of distribution and characteristics of spinal disorders using a validated questionnaire in a group of male subjects not exposed to occupational spinal risk factors. Spine. 1993, 18: 1150-1159. 10.1097/00007632-199307000-00006.View ArticlePubMedGoogle Scholar
- Arroyo JF, Jolliet P, Junod AF: Costovertebral joint dysfunction: another misdiagnosed cause of atypical chest pain. Postgrad Med J. 1992, 68: 655-659.View ArticlePubMedPubMed CentralGoogle Scholar
- Jensen S: Musculoskeletal causes of chest pain. Aust Fam Physician. 2001, 30: 834-839.PubMedGoogle Scholar
- Frobert O, Fossgreen J, Sondergaard-Petersen J, Hede J, Bagger JP: Musculo-skeletal pathology in patients with angina pectoris and normal coronary angiograms. J Intern Med. 1999, 245: 237-246. 10.1046/j.1365-2796.1999.0433e.x.View ArticlePubMedGoogle Scholar
- Triano JJ, Erwin M, Hansen DT: Costovertebral and costotransverse joint pain: A commonly overlooked pain generator. Top Clin Chiro. 1999, 6: 79-92.Google Scholar
- DeFranca GG, Levine LJ: The T4 syndrome. J Manipulative Physiol Ther. 1995, 18: 34-37.PubMedGoogle Scholar
- Flynn TW: Thoracic spine and ribcage disorders. Orthopaedic Physical Therapy Clinics of North America. 1999, 8: 1-20.Google Scholar
- McGuckin N: The T4 Syndrome. 1986, London: Churchill LivingstoneGoogle Scholar
- Cohen MJ, Ezekiel J, Persellin RH: Costovertebral and costotransverse joint involvement in rheumatoid arthritis. Ann Rheum Dis. 1978, 37: 473-475. 10.1136/ard.37.5.473.View ArticlePubMedPubMed CentralGoogle Scholar
- Groen GJ, Baljet B, Boekelaar AB, Drukker J: Branches of the thoracic sympathetic trunk in the human fetus. Anat Embryol (Berl). 1987, 176: 401-411. 10.1007/BF00310082.View ArticleGoogle Scholar
- Lau LS, Littlejohn GO: Costotransverse joint injection: A description of technique. Australas Radiol. 1987, 31 (1): 47-49. 10.1111/j.1440-1673.1987.tb01781.x.View ArticlePubMedGoogle Scholar
- Jensen MP, Turner JA, Romano JM: What is the maximum number of levels needed in pain intensity measurement?. Pain. 1994, 58: 387-392. 10.1016/0304-3959(94)90133-3.View ArticlePubMedGoogle Scholar
- McCormack HM, Horne DJ, Sheather S: Clinical applications of visual analogue scales: a critical review. Psychol Med. 1988, 18: 1007-1019.View ArticlePubMedGoogle Scholar
- Price DD, Bush FM, Long S, Harkins SW: A comparison of pain measurement characteristics of mechanical visual analogue and simple numerical rating scales. Pain. 1994, 56: 217-226. 10.1016/0304-3959(94)90097-3.View ArticlePubMedGoogle Scholar
- Manchikanti L, Manchikanti KN, Manchukonda R, Pampati V, Cash KA: Evaluation of therapeutic thoracic medial branch block effectiveness in chronic thoracic pain: a prospective outcome study with minimum 1-year follow up. Pain Physician. 2006, 9: 97-105.PubMedGoogle Scholar
- Manchikanti L, Singh V, Pampati V, Beyer CD, Damron KS: Evaluation of the prevalence of facet joint pain in chronic thoracic pain. Pain Physician. 2002, 5: 354-359.PubMedGoogle Scholar
- Manchukonda R, Manchikanti KN, Cash KA, Pampati V, Manchikanti L: Facet joint pain in chronic spinal pain: an evaluation of prevalence and false-positive rate of diagnostic blocks. J Spinal Disord Tech. 2007, 20: 539-545. 10.1097/BSD.0b013e3180577812.View ArticlePubMedGoogle Scholar
- Manchikanti L, Boswell MV, Singh V, Pampati V, Damron KS, Beyer CD: Prevalence of facet joint pain in chronic spinal pain of cervical, thoracic, and lumbar regions. BMC Musculoskelet Disord. 2004, 5: 15-10.1186/1471-2474-5-15.View ArticlePubMedPubMed CentralGoogle Scholar
- Igarashi A, Kikuchi S, Konno S, Olmarker K: Inflammatory cytokines released from the facet joint tissue in degenerative lumbar spinal disorders. Spine. 2004, 29: 2091-2095. 10.1097/01.brs.0000141265.55411.30.View ArticlePubMedGoogle Scholar
- Dreyfuss P, Rogers J, Dreyer S, Fletcher D: Atlanto-occipital joint pain. A report of three cases and description of an intraarticular joint block technique. Reg Anesth. 1994, 19: 344-351.PubMedGoogle Scholar
- Moore KL: Clinically Oriented Anatomy. 1992, Baltimore: Williams & WilkinsGoogle Scholar
- Hayek R, Henderson CNR, Hayek AFE: Unique features of the thoracic spine: Impact on chiropractic management. Top Clin Chiro. 1999, 6: 69-78.Google Scholar
- Galiano K, Obwegeser AA, Bodner G, Freund MC, Gruber H, Maurer H, Schatzer R, Fiegele T, Ploner F: Ultrasound-guided facet joint injections in the middle to lower cervical spine: a CT-controlled sonoanatomic study. Clin J Pain. 2006, 22: 538-543. 10.1097/01.ajp.0000202977.98420.27.View ArticlePubMedGoogle Scholar
- Galiano K, Obwegeser AA, Bodner G, Freund M, Maurer H, Kamelger FS, Schatzer R, Ploner F: Ultrasound guidance for facet joint injections in the lumbar spine: a computed tomography-controlled feasibility study. Anesth Analg. 2005, 101: 579-83. 10.1213/01.ANE.0000158609.64417.93.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2474/9/140/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.